Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

40.6%

Threshold

Crossed upwards

Timeline

Published

19.11.2022

Transaction

11.11.2022

Transfer date

16.11.2022

Voting rights breakdown

Voting rights acquired40.6%

Voting rights sold32.94%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAMBG00039

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

Crossing down of 33 1/3% thresholds on sale position following the exercise of pre-funded warrants.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd19.11.2022TAMBG00039

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the acquisition side, published by SIX Exchange Regulation on 19.11.2022, at 40.6% of voting rights. Notice category: Single shareholder.

Disclosed position

40.6%

Voting rights acquired

Voting rights acquired40.6%

Voting rights sold32.94%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 19.11.2022.

Publication date19.11.2022

Transaction date11.11.2022

Transfer date16.11.2022

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired40.6%

Voting rights sold32.94%

Below threshold0%

ExchangeXSWX

Notification IDTAMBG00039

Commercial register

CHE-113.514.094

Registered

Zefix record

Conditions

Crossing down of 33 1/3% thresholds on sale position following the exercise of pre-funded warrants.

Source: SIX Exchange Regulation · Publication date: 19.11.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open